Global Medical-grade Polylactide (PLA) Market Insights, Forecast to 2028

Medical Polylactic Acid Is A Condensed Polymer Of Lactic Acid. Lactic Acid Molecules Have L - And I) Optical Isomers, Commonly Used Is B And 17 - Mixture Of Polylactic Acid F. Human Body Is Non-Toxic, Especially Hemolysis, Has Good Biocompatibility, Can Be Degraded Into Lactic Acid In The Human Body, Through Metabolism Into Carbon Dioxide And Water Discharged From The Body. Its Fiber Ur Can Be Made Into Absorbable Sutures, Fiber Woven Fabrics Or Membrane Materials, Which Can Be Used As Repair Materials Of Human Tissues, Such As Anti Adhesion Membrane Of Muscle Tissue And Isolation Membrane Of Periosteum Growth;'E. Materials Compounded With Calcium Phosphate Or Carbon Fiber Can Be Used As Bone Plate; In Addition, It Can Be Used As Slow-Release Carrier For Injection Or Positioning Of Human Drugs
Market Analysis and Insights: Global Medical-grade Polylactide (PLA) Market
Due to the COVID-19 pandemic, the global Medical-grade Polylactide (PLA) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Medical L-Polylactide accounting for % of the Medical-grade Polylactide (PLA) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Medical Implants segment is altered to an % CAGR throughout this forecast period.
China Medical-grade Polylactide (PLA) market size is valued at US$ million in 2021, while the US and Europe Medical-grade Polylactide (PLA) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical-grade Polylactide (PLA) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Medical-grade Polylactide (PLA) include Corbion, Evonik Industries, NatureWorks, Futerro, Shenzhen Maiqi biomaterials Co., Ltd, Changchun SinoBiomaterials Co Ltd, Shenzhen Lvbao Technology Co., Ltd and SDSYXS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Medical-grade Polylactide (PLA) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medical-grade Polylactide (PLA) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Medical-grade Polylactide (PLA) Scope and Segment
Medical-grade Polylactide (PLA) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical-grade Polylactide (PLA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medical L-Polylactide
Medical Racemic Polylactide
Segment by Application
Medical Implants
Tissue Engineering
Orthopedic Equipment
Drug Delivery System
Dental Applications
3D Bioprinting Materials
By Company
Corbion
Evonik Industries
NatureWorks
Futerro
Shenzhen Maiqi biomaterials Co., Ltd
Changchun SinoBiomaterials Co Ltd
Shenzhen Lvbao Technology Co., Ltd
SDSYXS
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE